Romano Brothers & Co’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Romano Brothers & Co's MDT Position: Q2 2026 in Review
Romano Brothers & Co reduced its Medtronic (MDT) stake by 8.7% in Q2 2026, selling an estimated $235K and leaving 30,757 shares worth $2.41M. The position accounts for 0.24% of the portfolio, ranked #106.
Romano Brothers & Co first reported a position in MDT in Q3 2022 and has held it in 16 quarters since. The position peaked at $5.55M in Q3 2022. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Romano Brothers & Co held 30,757 shares of Medtronic worth $2.41M as of Q2 2026.
- Romano Brothers & Co sold 2,919 Medtronic shares in Q2 2026, an estimated $235K.
- Medtronic made up 0.24% of Romano Brothers & Co's portfolio in Q2 2026, its #106 holding.
- Romano Brothers & Co first reported a position in Medtronic in Q3 2022 and has held it in 16 quarters since.
- Romano Brothers & Co's Medtronic position peaked at $5.55M in Q3 2022.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.